Zinc Bisglycinate: The Chelated Zinc Form With Better Absorption and Tolerability
Zinc bisglycinate is the form of zinc with the best fractional absorption and substantially better GI tolerability than sulfate or oxide. For daily supplementation at 15–30 mg elemental, it is the form most likely to produce adherence and serum zinc rise. For acute lozenge use against colds, switch to zinc acetate or gluconate instead — that's a different indication with different chemistry.
Zinc is one of the few supplements where the chemical form on the label can genuinely change what reaches the bloodstream and how the dose feels in the stomach. The cheap default forms — zinc oxide and zinc sulfate — are workhorses but have drawbacks: oxide is poorly soluble and absorbed inconsistently, and sulfate is a well-known gastric irritant at higher doses. Zinc bisglycinate, a chelated form in which the zinc ion is held between two glycine molecules, sits at the more-absorbable, better-tolerated end of the spectrum. The advantage is real but modest, and it is most relevant for people taking zinc daily over the long term — not a reason to overhaul a regimen that already works.
What "bisglycinate" actually means
Zinc bisglycinate is a coordination complex: one zinc cation chelated by two glycine molecules, forming a small, largely neutral metal–amino-acid compound (an "amino acid chelate"). The theory behind the form is twofold. First, the chelate is thought to be absorbed partly through peptide and amino-acid transport routes rather than relying entirely on the divalent-metal transporters that handle free zinc ions, which can raise the fraction absorbed. Second, because the zinc is bound rather than free, it is less available to irritate the gastric lining or to be tied up by dietary phytate from grains and legumes. These are plausible mechanisms supported by absorption data, but it is worth being clear that much of the published zinc-glycinate literature comes from animal-production research (poultry, swine), and the human comparative data are more limited than marketing implies.
The absorption evidence
The cleanest human comparison is a randomized crossover study in 12 healthy women that compared a single 15 mg oral dose of zinc bis-glycinate against zinc gluconate and measured serum zinc over time. Bis-glycinate increased the bioavailability of zinc by about 43% relative to gluconate (based on area under the curve), and was safe and well tolerated [1]. A 2024 narrative review of the human studies comparing different zinc salts concluded that zinc glycinate and zinc gluconate are better absorbed than other common forms such as oxide [2] — though this review was authored by scientists at a supplement company, which is a relevant conflict of interest, and it is a narrative rather than a quantitative meta-analysis. The honest summary is that bisglycinate is among the better-absorbed forms, with the strongest single piece of human evidence being an advantage over gluconate; sweeping percentage claims against every other salt go beyond what the data cleanly support.
The tolerability question
Zinc's dose-limiting side effect is gastrointestinal: nausea and stomach upset, especially with zinc sulfate taken on an empty stomach, which is a recurring reason people abandon zinc supplementation. The case for bisglycinate is that a bound, less-irritating form should be gentler, and in the human studies that have used it, it has been reported as well tolerated — for example, the bioavailability crossover above reported no tolerability problems [1], and a 2025 dermatology study using oral zinc bisglycinate at 50 mg twice daily for eight weeks reported no increase in adverse effects [3]. What is missing is a large head-to-head trial directly measuring nausea rates for bisglycinate versus sulfate at matched doses in the same people, so precise numbers should be treated cautiously. The practical, well-supported advice is simpler: if zinc upsets your stomach, taking it with food and choosing a gentler chelated form both help.
When the form doesn't matter
Form is not universal. For zinc lozenges used acutely against the common cold, the active principle is ionic zinc released into the throat, and the evidence specifically favors high-dose zinc acetate lozenges (more than 75 mg elemental per day), which shortened cold duration in a pooled analysis [4]; a chelated form like bisglycinate that resists dissociating in saliva is the wrong tool for that job. For zinc carnosine used for gastric protection, the carnosine ligand does additional work and is not interchangeable with bisglycinate — see our piece on zinc carnosine. For broader context, see our zinc immunity overview and pediatric zinc guidance.
Dose, copper, and timing
For general daily supplementation, 15–30 mg of elemental zinc per day is reasonable and covers the range used in most trials; check the label, since bisglycinate's elemental zinc is a fraction of the total compound weight. The single most important safety point is copper: sustained zinc intake above roughly 40 mg per day can induce copper deficiency, which has its own hematological and neurological consequences, so long-term higher-dose users should ensure adequate copper. Zinc also competes for absorption with iron and calcium, so separating those by a couple of hours is sensible. And if any form still bothers your stomach, take it with a meal — the small absorption penalty is a fair trade for actually staying on it.
Sources
- Gandia P, Bour D, Maurette JM, et al. "A bioavailability study comparing two oral formulations containing zinc (Zn bis-glycinate vs. Zn gluconate) after a single administration to twelve healthy female volunteers." International Journal for Vitamin and Nutrition Research, 2007;77(4):243-248. PMID 18271278.
- Devarshi PP, Mao Q, Grant RW, Hazels Mitmesser S. "Comparative Absorption and Bioavailability of Various Chemical Forms of Zinc in Humans: A Narrative Review." Nutrients, 2024;16(24):4269. PMID 39770891.
- Noaimi AA, Mohamed M. "The Treatment of Acute Cutaneous Leishmaniasis With Oral Zinc Bisglycinate and Oral Hydroxychloroquine Sulfate." Cureus, 2025;17(5):e84618. PMID 40546545.
- Hemilä H. "Zinc lozenges may shorten the duration of colds: a systematic review." The Open Respiratory Medicine Journal, 2011;5:51-58. PMID 21769305.